The Stock Price of UnitedHealth Group Still Falls More Than 30% from Two Years Ago, and Policy Dependency Becomes a Key Investment Consideration Jun 12, 2026 Life Science
The iShares U.S. Pharmaceutical ETF Has Achieved a Return of Over 42% in the Past Year Jun 11, 2026 Life Science
Market Embraces R&D Pipeline Progress, Moderna’s Stock Soars on Cancer Vaccine Prospects Jun 9, 2026 Life Science
The Economic Outlook Clouds Over, Weighing on the Market, but Two Pharmaceutical Giants May Buck the Trend Jun 8, 2026 Life Science
Strong Demand for GLP-1 Drugs Drives Eli Lilly’s Leadership with New Oral Medication and Acquisitions Jun 4, 2026 Life Science
Gene Editing Could Become the Next “Golden Rush” in the Pharmaceutical Industry, What Does This Mean for CRISPR Therapeutics? Jun 3, 2026 Life Science
AbbVie Faces a Challenger in Johnson & Johnson, but Investors Need Not Panic Jun 3, 2026 Life Science
Bristol-Myers Squibb’s Stock Looks Cheap on the Surface, but Hidden Risks Lurk Beneath Jun 2, 2026 Life Science
After the Market Pullback, the Defensive Value of Two Blue-Chip Stocks Stands Out May 29, 2026 Life Science, Technology
Riding on Strong Earnings and a $1.5 Billion Market Catalyst, Exelixis Is Poised for Takeoff May 28, 2026 Life Science
